COMPETITIVE POLYMERASE CHAIN-REACTION QUANTITATION OF C-ERBA-BETA-1, C-ERBA-ALPHA-1, AND C-ERBA-ALPHA-2 MESSENGER-RIBONUCLEIC-ACID LEVELS IN NORMAL, HETEROZYGOUS, AND HOMOZYGOUS FIBROBLASTS OF KINDRED-S WITH THYROID-HORMONE RESISTANCE

被引:14
作者
KLANN, RC
TORRES, B
MENKE, JB
HOLBROOK, CT
BERCU, BB
USALA, SJ
机构
[1] E CAROLINA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, GREENVILLE, NC 27858 USA
[2] E CAROLINA UNIV, SCH MED, DEPT MED, GREENVILLE, NC 27858 USA
[3] UNIV S FLORIDA, COLL MED, DEPT PEDIAT, TAMPA, FL 33612 USA
[4] UNIV S FLORIDA, COLL MED, DEPT PHARMACOL & THERAPEUT, TAMPA, FL 33612 USA
关键词
D O I
10.1210/jc.77.4.969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the T3-binding domain of the thyroid hormone receptor gene c-erbAbeta result in dominant negative proteins and thyroid hormone resistance syndromes. Variable clinical manifestations of resistance to thyroid hormones have been reported, including short stature and neuropsychological abnormalities. The molecular bases for heterogeneity of phenotype among and within kindreds have not been fully elucidated. Recent investigations have considered differential expression of mutant and wild-type beta1-receptor alleles and the regulation thereof as a mechanism to explain differential sensitivity to thyroid hormones. We used reverse transcription-competitive polymerase chain reaction (PCR) to measure c-erbAbeta1, c-erbAalpha1, and c-erbAalpha2 mRNAs in skin fibroblasts cultured from normal subjects, heterozygotes, and a severely affected homozygous mutant of kindred S. The homozygous mutant of kindred S had severe growth and mental retardation. After reverse transcription with primers specific for each of the c-erbA mRNAs, first strand cDNAs were amplified by PCR using subtype-specific amplimers. Primer design allowed simultaneous detection of wild-type and mutant messages in heterozygous fibroblasts and showed an approximately 1:1 ratio of these mRNAs in three patients. Inclusion of competitive standard cDNAs of known concentration in the PCR reactions allowed quantitation of the absolute levels of the beta1-, alpha1-, and alpha2 mRNAs by comparison of products on ethidium bromide-stained agarose gels. These studies showed no effect of the presence of the mutant beta1-allele, as fibroblast RNA from normal subjects, heterozygotes, and the homozygote gave values of 56-184, 2.8-12, and 23-40 attomol/5 mug total RNA for beta1-, alpha1, and alpha2 mRNAs, respectively. We conclude that these sensitive methods allow the detection of molecular species present at levels as low as 10 molecules/cell, and that this potent dominant negative receptor does not disrupt c-erbA expression at the level of mRNA. The neuropsychological sequelae of the kindred S mutation are not due to relative overexpression of the mutant allele.
引用
收藏
页码:969 / 975
页数:7
相关论文
共 29 条
[1]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P130
[2]   AN ARGININE TO HISTIDINE MUTATION IN CODON 311 OF THE C-ERBA-BETA GENE RESULTS IN A MUTANT THYROID-HORMONE RECEPTOR THAT DOES NOT MEDIATE A DOMINANT NEGATIVE PHENOTYPE [J].
GEFFNER, ME ;
SU, F ;
ROSS, NS ;
HERSHMAN, JM ;
VANDOP, C ;
MENKE, JB ;
HAO, E ;
STANZAK, RK ;
EATON, T ;
SAMUELS, HH ;
USALA, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) :538-546
[3]   ANALYSIS OF CYTOKINE MESSENGER-RNA AND DNA - DETECTION AND QUANTITATION BY COMPETITIVE POLYMERASE CHAIN-REACTION [J].
GILLILAND, G ;
PERRIN, S ;
BLANCHARD, K ;
BUNN, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2725-2729
[4]  
Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60
[5]   EXPRESSION OF BETA-AMYLOID PROTEIN-PRECURSOR MESSENGER-RNAS - RECOGNITION OF A NOVEL ALTERNATIVELY SPLICED FORM AND QUANTITATION IN ALZHEIMERS-DISEASE USING PCR [J].
GOLDE, TE ;
ESTUS, S ;
USIAK, M ;
YOUNKIN, LH ;
YOUNKIN, SG .
NEURON, 1990, 4 (02) :253-267
[6]   THE RELATIVE EXPRESSION OF MUTANT AND NORMAL THYROID-HORMONE RECEPTOR GENES IN PATIENTS WITH GENERALIZED RESISTANCE TO THYROID-HORMONE DETERMINED BY ESTIMATION OF THEIR SPECIFIC MESSENGER-RIBONUCLEIC-ACID PRODUCTS [J].
HAYASHI, Y ;
JANSSEN, OE ;
WEISS, RE ;
MURATA, Y ;
SEO, H ;
REFETOFF, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :64-69
[7]  
Higuchi R., 1989, PCR TECHNOLOGY PRINC, P61
[8]   THYROID-HORMONE RESISTANCE SYNDROME - INHIBITION OF NORMAL RECEPTOR FUNCTION BY MUTANT THYROID-HORMONE RECEPTORS [J].
KRISHNA, V ;
CHATTERJEE, K ;
NAGAYA, T ;
MADISON, LD ;
DATTA, S ;
RENTOUMIS, A ;
JAMESON, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :1977-1984
[9]   FAMILIAL GENERALIZED RESISTANCE TO THYROID-HORMONES - REPORT OF 3 KINDREDS AND CORRELATION OF PATTERNS OF AFFECTED TISSUES WITH THE BINDING OF [I-125] TRIIODOTHYRONINE TO FIBROBLAST NUCLEI [J].
MAGNER, JA ;
PETRICK, P ;
MENEZESFERREIRA, MM ;
STELLING, M ;
WEINTRAUB, BD .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1986, 9 (06) :459-470
[10]   VARIABLE TRANSCRIPTIONAL ACTIVITY AND LIGAND-BINDING OF MUTANT BETA-1 3,5,3'-TRIIODOTHYRONINE RECEPTORS FROM 4 FAMILIES WITH GENERALIZED RESISTANCE TO THYROID-HORMONE [J].
MEIER, CA ;
DICKSTEIN, BM ;
ASHIZAWA, K ;
MCCLASKEY, JH ;
MUCHMORE, P ;
RANSOM, SC ;
MENKE, JB ;
HAO, EH ;
USALA, SJ ;
BERCU, BB ;
CHENG, SY ;
WEINTRAUB, BD .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (02) :248-258